We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Low body weight and type of protease inhibitor predict discontinuation and treatment-limiting adverse drug reactions among HIV-infected patients starting a protease inhibitor regimen: consistent results from a randomized trial and an observational cohort.
- Authors
Kirk, O; Gerstoft, J; Pedersen, C; Nielsen, H; Obel, N; Katzenstein, T L; Mathiesen, L; Lundgren, J D
- Abstract
To assess predictors for discontinuation and treatment-limiting adverse drug reactions (TLADR) among patients starting their first protease inhibitor (PI).
- Publication
HIV medicine, 2001, Vol 2, Issue 1, p43
- ISSN
1464-2662
- Publication type
Journal Article
- DOI
10.1046/j.1468-1293.2001.00045.x